Menu Search
Equities

Shinva Medical Instrument Co Ltd

600587:SHH

Shinva Medical Instrument Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)18.00
  • Today's Change-0.56 / -3.02%
  • Shares traded10.35m
  • 1 Year change-3.31%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shinva Medical Instrument Co Ltd grew revenues 7.87% from 9.28bn to 10.01bn while net income improved 30.78% from 500.07m to 654.00m.
Gross margin25.62%
Net profit margin6.96%
Operating margin7.85%
Return on assets4.72%
Return on equity9.42%
Return on investment9.14%
More ▼

Cash flow in CNYView more

In 2023, Shinva Medical Instrument Co Ltd increased its cash reserves by 108.58%, or 1.58bn. Cash Flow from Financing totalled 1.07bn or 10.65% of revenues. In addition the company generated 1.03bn in cash from operations while cash used for investing totalled 519.90m.
Cash flow per share--
Price/Cash flow per share--
Book value per share12.34
Tangible book value per share11.13
More ▼

Balance sheet in CNYView more

Shinva Medical Instrument Co Ltd has a Debt to Total Capital ratio of 16.37%, a higher figure than the previous year's 2.53%.
Current ratio1.31
Quick ratio0.8303
Total debt/total equity0.2067
Total debt/total capital0.1637
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 233.32% and 16.26%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is above the industry average.
Div yield(5 year avg)0.93%
Div growth rate (5 year)61.86%
Payout ratio (TTM)33.70%
EPS growth(5 years)91.14
EPS (TTM) vs
TTM 1 year ago		23.62
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.